Inspire Corporate Bond ETF (IBD) is a publicly traded the market company. As of May 21, 2026, IBD trades at $23.80 with a market cap of $0 and a P/E ratio of 0.00. IBD moved +0.00% today. Year to date, IBD is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $0.00 to $0.00. Rallies surfaces IBD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Hedge funds tracked by Rallies that own IBD include Citadel Advisors. The latest tracked quarter is Dec 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Inspire Corporate Bond ETF.
| Metric | Value |
|---|---|
| Price | $23.80 |
| Market Cap | $0 |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $0.00 |
| 52-Week Low | $0.00 |
| Volume | 139.86K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
IBD analyst coverage data. Average price target: $0.00.